| Literature DB >> 21034436 |
Amel Nakbi1, Wafa Tayeb, Abir Grissa, Manel Issaoui, Samia Dabbou, Issam Chargui, Meriem Ellouz, Abdelhedi Miled, Mohamed Hammami.
Abstract
BACKGROUND: Olive oil's beneficial effects are not only related to its high content of oleic acid, but also to the antioxidant potential of its polyphenols. In this study, we assess the effects of virgin olive oil and its fractions on 2,4-D- induced oxidative damage in the liver of rats.Entities:
Year: 2010 PMID: 21034436 PMCID: PMC2987329 DOI: 10.1186/1743-7075-7-80
Source DB: PubMed Journal: Nutr Metab (Lond) ISSN: 1743-7075 Impact factor: 4.169
Mean values of analytical parameters, fatty acids composition (%), oxidative stability and antioxidant content of extra virgin olive oil, hydrophilic fraction, lipophilic fractions and standard diet fed to rat.
| Extra virgin olive oil | Lipophilic fraction | Hydrophilic fraction | Standard diet | |
|---|---|---|---|---|
| Palmitic acid [%] | 10.28 ± 0.04a | 10.40 ± 0.01a | - | 11.62 ± 0.85a |
| Palmitoleic acid | 0.77 ± 0.30a | 0.79 ± 0.60a | - | 0.10 ± 0.04 a |
| Stearic acid | 3.39 ± 0.14a | 3.56 ± 0.37a | - | 1.15 ± 0.32 b |
| Oleic acid | 64.80 ± 1.99 a | 62.58 ± 3.71 a | - | 29.73 ± 1.12 b |
| Linoleic acid | 14.34 ± 0.90 b | 15.04 ± 0.54 b | - | 53.89 ± 1.49a |
| Linolenic acid | 0.64 ± 0.04a | 0.68 ± 0.03 a | - | 0.61 ± 0.02 a |
| Arachidic acid | 0.74 ± 0.05a | 0.78 ± 0.02a | - | 0.09 ± 0.04 b |
| Gadoleic acid | 0.62 ± 0.03a | 0.57 ± 0.03a | - | 0.14 ± 0.04 b |
| Behenic acid | 2.84 ± 0.37a | 2.87 ± 0.80a | - | 0.22 ± 0.10 b |
| SFA | 17.28 ± 0.22a | 17.62 ± 0.42 a | - | 13.08 ± 0.21 b |
| MUFA | 66.20 ± 2.34 a | 63.95 ± 3.07 a | - | 29.97 ± 1.32 b |
| PUFA | 14.99 ± 0.94b | 15.72 ± 0.57b | - | 54.50 ± 2.12a |
| MUFA/PUFA | 4.43 ± 0.43 a | 4.07 ± 0.04a | - | 0.54 ± 0.32 b |
| OSI (h) | 9.6a | 4.7 b | - | - |
| Chlorophylls (mg/kg) | 12.65 ± 0.29a | 5.4 ± 0.76 b | - | ND |
| β-Carotene (mg/kg) | 7.15 ± 0.20 a | 5.43 ± 0.08 b | - | ND |
| Total polyphenols (mg/kg) | 579.17 ± 71.40*a | - | 192.00 ± 11.59**b | ND |
| α- tocopherol (mg/kg) | 484.56 ± 11.11a | 491.64 ± 10.36a | - | 224 ± 11.86 b |
Data are expressed as mean values ± of three independent experiments. SFA: saturated fatty acids; MUFA: monounsaturated fatty acid; PUFA: polyunsaturated fatty acid; OSI: oxidative stability Index. ND: indicates not determined
Values followed by same letters are not significantly different. (Tukey's test, p < 0.05)
* As hydroxytyrosol equivalents (mg/kg EVOO)
** As expressed mg of hydroxytyrosol equivalents/kg of OOHF
Body weight, weight gain, relative liver weight of control and experimental rats
| Parameters and groups | Initial body weight (g) | Final body weight (g) | Weight gain (%) | Relative liver weight (g/100 g body weight) |
|---|---|---|---|---|
| C | 216.80 ± 18.10 | 273.70 ± 27.10 | 26.16 ± 4.05 | 3.11 ± 0.32 |
| D | 220.00 ± 11.11 | 276.70 ± 15.23 | 25.62 ± 5.66 | 3.56 ± 0.30§§ |
| D/EVOO | 222.80 ± 19.03 | 280.60 ± 19.77 | 26.21 ± 6.15 | 3.59 ± 0.23§§ |
| D/OOHF | 222.60 ± 25.29 | 279.10 ± 34.74 | 25.32 ± 5.67 | 3.47 ± 0.28§ |
| D/OOLF | 219.10 ± 16.17 | 277.40 ± 21.66 | 26.69 ± 5.90 | 3.36 ± 0.25 |
| EVOO | 221.30 ± 22.84 | 271.10 ± 22.96 | 22.81 ± 6.10 | 3.50 ± 0.21§ |
| OOHF | 225.50 ± 23.10 | 286.10 ± 25.86 | 27.08 ± 4.33 | 3.43 ± 0.21§ |
| OOLF | 221.50 ± 30.64 | 284.50 ± 29.53 | 29.82 ± 6.85 | 3.36 ± 0.11 |
Data are expressed as means ± SD (n = 10 rats per group). C: controls group, D: 2, 4-D treated group, D/EVOO: 2, 4-D plus extra virgin olive oil, D/OOHF: 2, 4-D plus hydrophilic fraction, D/OOLF: 2, 4-D plus lipophilic fraction, EVOO: extra virgin olive oil treated group alone, OOHF: group treated with hydrophilic fraction of olive oil alone, OOLF: group treated with lipophilic fraction of olive oil alone. Comparison between groups was made using unpaired Student t test.
* p < .05 (compared to Group D)
§§ p < .01; § p < .05 (compared to controls C)
Effects of extra virgin olive oil (EVOO) and its fractions (OOHF and OOLF) on biochemical indicators of liver function (AST, ALT, ALP, γ-GT and total bilirubin) in serum of rat treated or not with 2,4-D.
| Groups | AST | ALT | ALP | γ-GT | T-Bilirubin |
|---|---|---|---|---|---|
| C | 96.40 ± 17.07 | 33.75 ± 3.24 | 109.80 ± 13.62 | 20.20 ± 3.76 | 5.66 ± 1.18 |
| D | 138.16 ± 12.44§§ | 57.50 ± 10.60§§ | 157.57 ± 27.09§§ | 32.00 ± 2.94§§ | 12.05 ± 0.81§§ |
| D/EVOO | 97.71 ± 13.57 ** | 38.00 ± 3.16** | 123.33 ± 20.81 | 34.14 ± 5.81§§ | 7.00 ± 0.91** |
| D/OOHF | 94.16 ± 10.72** | 35.40 ± 3.20** | 127 ± 23.64 | 30.14 ± 12.40 | 7.56 ± 1.70**§ |
| D/OOLF | 103.50 ± 12.55** | 31.28 ± 4.46** | 194.25 ± 12.81**§§ | 34.60 ± 12.09§ | 7.42 ± 0.61**§ |
| EVOO | 94.60 ± 6.69 | 34.83 ± 4.35 | 107.00 ± 24.73 | 25.00 ± 8.64 | 6.14 ± 1.09 |
| OOHF | 95.83 ± 10.79 | 29.44 ± 3.43 | 123.60 ± 28.83 | 22.57 ± 7.36 | 6.86 ± 1.33 |
| OOLF | 96.37 ± 9.85 | 32.66 ± 3.44 | 119.00 ± 10.98 | 30.60 ± 7.16§ | 5.58 ± 1.68 |
Student t test (C: controls group, D: 2,4-D treated group, D/EVOO: 2,4-D plus extra virgin olive oil, D/OOHF: 2,4-D plus hydrophilic fraction, D/OOLF: 2,4-D plus lipophilic fraction, EVOO: extra virgin olive oil treated group alone, OOHF: group treated with hydrophilic fraction of olive oil, OOLF: group treated with lipophilic fraction of olive oil.
** p <.01; * p < .05 (compared to Group D)
§§ p < .01; § p < .05 (compared to controls C)
Effects of extra virgin olive oil (EVOO) and its fractions (OOHF and OOLF) on antioxidant enzymes activities in liver of rat treated or not with 2,4-D.
| Groups | Antioxidant enzyme activity (U/mg liver protein) | |||
|---|---|---|---|---|
| SOD | CAT | GPX | GR | |
| C | 9.49 ± 1.34 | 23.42 ± 0.53 | 0.75 ± 0.20 | 0.05 ± 0.0035 |
| D | 6.71 ± 1.58§ | 14.51 ± 1.01§§ | 0.30 ± 0.09§ | 0.037 ± 0.007§ |
| D/EVOO | 13.38 ± 1.76* | 20.29 ± 0.68§§** | 0.80 ± 0.27* | 0.056 ± 0.01* |
| D/OOHF | 8.13 ± 0.97 | 22.50 ± 1.29** | 0.76 ± 0.27* | 0.053 ± 0.005* |
| D/OOLF | 6.45 ± 0.96§ | 15.96 ± 0.28§§ | 0.55 ± 0.05* | 0.031 ± 0.011§ |
| EVOO | 9.65 ± 1.13 | 22.50 ± 1.29 | 0.86 ± 0.39 | 0.051 ± 0.003 |
| OOHF | 9.53 ± 0.59 | 22.71 ± 0.52 | 0.74 ± 0.17 | 0.052 ± 0.008 |
| OOLF | 6.47 ± 1.33§ | 18.59 ± 1.09§§ | 0.51 ± 0.16 | 0.034 ± 0.013§ |
Data are expressed as means ± SD (n = 10 rats per group). Comparison between groups was made using unpaired Student t test. (C: controls group, D: 2, 4-D treated group, D/EVOO: 2, 4-D + extra virgin olive oil, D/OOHF: 2, 4-D+ hydrophilic fraction, D/OOLF: 2,4-D+ lipophilic fraction, EVOO: extra virgin olive oil treated group alone, OOHF: group treated with hydrophilic fraction of olive oil, OOLF: group treated with lipophilic fraction of olive oil.* P < .05 vs 2,4-D group; ** P < .01 vs 2,4-D group. § P < .05 vs. control group; §§ P < .01 vs. control group.
Figure 1Malondialdehyde (MDA) and conjugated dienes (CD) levels in liver of rat treated or not with 2,4-D under effects of supplemented extra virgin olive oil (EVOO) and its fractions (OOHF and OOLF). C: controls group, D: 2, 4-D treated group, D/EVOO: 2, 4-D + extra virgin olive oil, D/OOHF: 2, 4-D+ hydrophilic fraction, D/OOLF: 2,4-D+ lipophilic fraction, EVOO: extra virgin olive oil treated group alone, OOHF: group treated with hydrophilic fraction of olive oil, OOLF: group treated with lipophilic fraction of olive oil. Data are expressed as means ± SD (n = 10 rats per group). Comparison between groups was made using unpaired Student t test. * p < .05 vs 2,4-D group; § p < .05 vs control group.
Effects of extra virgin olive oil (EVOO) and its fractions (OOHF and OOLF) on liver fatty acid composition of rat treated or not with 2,4-D.
| Fatty acid (%) | C | D | D/EVOO | D/OOHF | D/OOLF | EVOO | OOHF | OOLF |
|---|---|---|---|---|---|---|---|---|
| C14:0 | 1.15 ± 0.11ab | 1.35 ± 0.11 a | 1.18 ± 016 ab | 1.19 ± 0.15 ab | 1.26 ± 0.15 ab | 1.05 ± 0.15 b | 1.13 ± 0.18 ab | 1.16 ± 0.16 ab |
| C14:1 | 0.46 ± 0.05 a | 0.31 ± 0.06 b | 0.48 ± 0.07 a | 0.47 ± 0.06 a | 0.44 ± 0.09 a | 0.48 ± 0.06 a | 0.48 ± 0.06 a | 0.40 ± 0.05 ab |
| C16:0 | 17.59 ± 0.81 a | 17.27 ± 0.72 ab | 16.71 ± 0.39 ab | 17.36 ± 0.38 ab | 16.64 ± 0.75 ab | 16.38 ± 0.22 b | 16.64 ± 0.73 ab | 16.98 ± 0.78 ab |
| C16:1 | 1.46 ± 0.25 a | 1.26 ± 0.11 a | 1.45 ± 0.31 a | 1.50 ± 0.32 a | 1.42 ± 0.26 a | 1.49 ± 0.28 a | 1.39 ± 0.07 a | 1.48 ± 0.26 a |
| C18:0 | 19.24 ± 0.54 c | 24.80 ± 0.71 a | 20.66 ± 0.46 b | 21.68 ± 0.49 b | 22.47 ± 1.86 b | 19.46 ± 0.26 c | 19.01 ± 0.44 c | 19.61 ± 0.90 c |
| C18:1 | 14.77 ± 0.42 b | 11.87 ± 0.30 c | 16.90 ± 0.70 b | 14.65 ± 0.20 b | 16.03 ± 0.50 b | 19.17 ± 0.72 a | 15.36 ± 0.77 b | 15.92 ± 0.37 b |
| C18:2 | 13.74 ± 0.68 ab | 14.17 ± 0.56 a | 12.70 ± 0.70 bc | 13.15 ± 0.82 abc | 14.27 ± 0.87 a | 12.12 ± 0.86 c | 13.04 ± 0.63 abc | 14.10 ± 0.61 a |
| C18:3 | 0.47 ± 0.06 a | 0.18 ± 0.06 c | 0.28 ± 0.08 bc | 0.29 ± 0.03 bc | 0.30 ± 0.04 b | 0.46 ± 0.07 a | 0.49 ± 0.08 a | 0.51 ± 0.09 a |
| C20:0 | 0.35 ± 0.02 c | 0.52 ± 0.18 a | 0.40 ± 0.04 bc | 0.39 ± 0.06 bc | 0.47 ± 0.07 ab | 0.33 ± 0.06 c | 0.37 ± 0.05 bc | 0.37 ± 0.07 bc |
| C20:1 | 0.50 ± 0.04 ab | 0.37 ± 0.04 b | 0.49 ± 0.12 ab | 0.54 ± 0.12 a | 0.48 ± 0.05 ab | 0.59 ± 0.13 a | 0.55 ± 0.12 a | 0.59 ± 0.04 a |
| C20:2 | 0.51 ± 0.07 ab | 0.64 ± 0.18 a | 0.44 ± 0.08 bc | 0.47 ± 0.10 abc | 0.48 ± 0.15 abc | 0.31 ± 0.09 c | 0.45 ± 0.10 bc | 0.40 ± 0.13 bc |
| C20:3 | 0.74 ± 0.07 a | 0.47 ± 0.08 a | 0.65 ± 0.13 a | 0.66 ± 0.09 a | 0.40 ± 0.07 b | 0.62 ± 0.12 a | 0.65 ± 0.02 a | 0.36 ± 0.03 b |
| C20:4 | 19.65 ± 1.29 ab | 17.77 ± 0.32 ab | 18.69 ± 1.73 ab | 19.26 ± 2.39 ab | 18.08 ± 2.01 ab | 16.96 ± 2.61 b | 20.80 ± 1.52 a | 18.33 ± 2.10 ab |
| C20:5 EPA | 0.51 ± 0.07 a | 0.36 ± 0.06 b | 0.48 ± 0.08 ab | 0.50 ± 0.06 ab | 0.47 ± 0.09 ab | 0.47 ± 0.06 ab | 0.53 ± 0.05 a | 0.51 ± 0.13 a |
| C22:0 | 0.50 ± 0.11 a | 0.52 ± 0.08 a | 0.53 ± 0.13 a | 0.55 ± 0.11 a | 0.45 ± 0.12 a | 0.44 ± 0.10 a | 0.44 ± 0.10 a | 0.46 ± 0.11 a |
| C22:4 | 0.32 ± 0.05 ab | 0.44 ± 0.18 a | 0.38 ± 0.08 ab | 0.36 ± 0.08 ab | 0.35 ± 0.10 ab | 0.28 ± 0.06 b | 0.37 ± 0.03 ab | 0.38 ± 0.15 ab |
| C22:1 | 0.60 ± 0.07 a | 0.54 ± 0.08 a | 0.73 ± 0.15 a | 0.65 ± 0.12 a | 0.61 ± 0.17 a | 0.76 ± 0.20 a | 0.62 ± 0.15 a | 0.72 ± 0.04 a |
| C22:5 | 0.65 ± 0.07 a | 0.51 ± 0.04 b | 0.74 ± 0.07 a | 0.62 ± 0.06 ab | 0.64 ± 0.10 a | 0.70 ± 0.05 a | 0.68 ± 0.09 a | 0.67 ± 0.06 a |
| C24:0 | 0.45 ± 0.09 a | 0.47 ± 0.03 a | 0.37 ± 0.04 a | 0.41 ± 0.08 a | 0.40 ± 0.08 a | 0.38 ± 0.06 a | 0.42 ± 0.08 a | 0.40 ± 0.09 a |
| C22:6 DHA | 4.59 ± 0.39 a | 4.38 ± 0.35 a | 4.36 ± 0.28 a | 4.60 ± 0.31 a | 4.40 ± 0.31 a | 4.24 ± 0.32 a | 4.48 ± 0.26 a | 4.38 ± 0.22 a |
| C24:1 | 0.32 ± 0.06 a | 0.19 ± 0.07 b | 0.38 ± 0.03 a | 0.33 ± 0.07 a | 0.34 ± 0.07 a | 0.40 ± 0.06 a | 0.37 ± 0.08 a | 0.38 ± 0.06 a |
| ΣSFA | 39.31 ± 0.97 cd | 44.95 ± 1.09 a | 39.88 ± 0.71 cd | 41.61 ± 0.80 b | 41.71 ± 2.30 b | 38.06 ± 0.25 d | 38.04 ± 1.07d | 39.00 ± 1.47 cd |
| ΣMUFA | 18.12 ± 0.52 d | 14.56 ± 0.30 e | 20.47 ± 1.11 b | 18.17 ± 0.51 d | 19.34 ± 0.62 bc | 22.91 ± 0.80 a | 18.78 ± 0.70 cd | 19.52 ± 0.58 bc |
| ΣPUFA | 41.22 ± 1.39 a | 38.95 ± 0.79 b | 38.75 ± 1.98 b | 39.96 ± 2.17 a | 39.43 ± 2.75 a | 36.19 ± 1.32 b | 41.53 ± 1.32 a | 39.68 ± 1.95 a |
| ΣUFA | 59.34 ± 1.86 a | 53.51 ± 0.96 b | 59.23 ± 2.00 a | 58.14 ± 2.44 a | 58.77 ± 2.32 a | 59.10 ± 1.63 a | 60.32 ± 1.53 a | 59.20 ± 1.75 a |
| MUFA/PUFA ratio | 0.43 ± 0.007 c | 0.37 ± 0.008 d | 0.52 ± 0.04 b | 0.45 ± 0.02c | 0.49 ± 0.04 bc | 0.63 ± 0.05 a | 0.45 ± 0.02 c | 0.49 ± 0.03 bc |
| PUFA/SFA ratio | 1.04 ± 0.04 ab | 0.86 ± 0.03d | 0.97 ± 0.05bc | 0.96 ± 0.04 bc | 0.94 ± 0.08 cd | 0.95 ± 0.04 cd | 1.09 ± 0.06 a | 1.01 ± 0.04 abc |
| SFA/UFA ratio | 0.66 ± 0.02 cd | 0.84 ± 0.02 a | 0.67 ± 0.03 cd | 0.71 ± 0.02 b | 0.71 ± 0.05b | 0.64 ± 0.01 d | 0.63 ± 0.03 d | 0.69 ± 0.07 b c |
Data are expressed by mean values ± of three independent experiments. SFA: saturated fatty acids; MUFA: monounsaturated fatty acid; PUFA: polyunsaturated fatty acid. Comparison between groups was made using one-way analysis of variance (ANOVA) followed by the Tukey test. Values followed by same letters are not significantly different. (C: controls group, D: 2, 4-D treated group, D/EVOO: 2, 4-D + extra virgin olive oil, D/OOHF: 2, 4-D+ hydrophilic fraction, D/OOLF: 2,4-D+ lipophilic fraction, EVOO: extra virgin olive oil treated group alone, OOHF: group treated with hydrophilic fraction of olive oil, OOLF: group treated with lipophilic fraction of olive oil.